Oncology

The Biology of HDGC: Why the "Glue" Matters

At a Glance

Hereditary Diffuse Gastric Cancer (HDGC) is caused by mutations in the CDH1 or CTNNA1 genes, which stop stomach cells from sticking together. This causes individual signet ring cancer cells to spread quietly throughout the stomach lining rather than forming a visible tumor lump.

To understand Hereditary Diffuse Gastric Cancer (HDGC), it helps to think of your body’s cells as bricks in a wall. In a healthy stomach, these “bricks” are held together by a powerful biological glue. When the genes responsible for making this glue are mutated, the wall doesn’t just crack—the bricks stop sticking together entirely ^[1]^[2].

The “Biological Glue”: CDH1 and CTNNA1

Most cases of HDGC are caused by a mutation in the CDH1 gene, which provides instructions for making a protein called E-cadherin ^[3]^[1].

E-cadherin (The Glue): This protein sits on the surface of cells and physically latches onto the E-cadherin of neighboring cells. This creates a tight, organized sheet of tissue ^[4]^[5].
Alpha-catenin (The Anchor): The CTNNA1 gene makes a protein called alpha-catenin. If E-cadherin is the glue on the outside, alpha-catenin is the internal anchor that secures that glue to the cell’s skeleton. If either the glue (CDH1) or the anchor (CTNNA1) is broken, the cells can no longer stay attached to one another ^[6]^[7].

A Note on Inheritance

Because HDGC is an autosomal dominant condition, each child of a carrier has a 50% chance of inheriting the mutation. This makes genetic counseling a critical step for your entire family ^[8].

Why “Diffuse” is Different

In most common stomach cancers (called intestinal-type), the cells stay stuck together and grow in a clump, eventually forming a visible tumor or “mass” ^[9]^[10].

HDGC is diffuse, meaning the cells are discohesive (they don’t stick). Instead of forming a single lump, individual cancer cells break away and spread quietly through the layers of the stomach wall ^[11]^[12].

Hard to See: Because there is no solid lump, HDGC is often invisible to standard CT scans or even regular endoscopies in its early stages ^[13]^[14].
Linitis Plastica: As these cells spread, they can cause the stomach wall to become thick and rigid, a condition sometimes called “leather bottle stomach” or linitis plastica ^[13]^[15].

What are Signet Ring Cells?

If your doctor mentions signet ring cells, they are describing the specific appearance of these discohesive cancer cells under a microscope.

The Appearance: Inside these cells, a large droplet of fluid called mucin builds up. This droplet is so large that it pushes the cell’s nucleus (its control center) over to the very edge ^[16]^[17].
The Name: Under the microscope, the pushed-aside nucleus looks like the “gem” of a ring, and the rest of the cell looks like the band, creating a shape reminiscent of an old-fashioned signet ring ^[16].

HDGC vs. Sporadic Cancer

Feature	Intestinal-Type (Sporadic)	Diffuse-Type (HDGC)
Structure	Forms a solid mass or lump ^[10]	Individual cells spread through the wall ^[11]
Cell Connection	Cells stick together (cohesive) ^[9]	Cells break apart (discohesive) ^[12]
Primary Cause	Often environmental (e.g., H. pylori infection) ^[9]	Genetic mutation (CDH1 or CTNNA1) ^[18]
Detection	Often visible on scans/standard endoscopy	Requires specialized “mapping” biopsies ^[19]

Understanding this biology explains why doctors take so many “random” biopsies during your exams. They aren’t looking for a single tumor; they are hunting for microscopic signet ring cells that could be anywhere in the stomach lining ^[20]^[19].

Next Steps: Learn how doctors monitor for these cells in Monitoring Your Health: Surveillance and the Cambridge Protocol.
Back to the start: Home Page

Common questions in this guide

What causes Hereditary Diffuse Gastric Cancer (HDGC)?

Most cases of HDGC are caused by a genetic mutation in the CDH1 or CTNNA1 genes. These genes provide instructions for creating E-cadherin and alpha-catenin, which act as a biological glue holding stomach cells together.

What are signet ring cells in stomach cancer?

Signet ring cells are specific cancer cells that contain a large droplet of fluid called mucin. This fluid pushes the cell's nucleus to the edge, making it look like an old-fashioned signet ring under a microscope.

How is diffuse gastric cancer different from sporadic stomach cancer?

Unlike common stomach cancer that forms a solid mass, diffuse gastric cancer cells do not stick together. Instead, individual cancer cells break apart and spread quietly through the layers of the stomach wall, making them hard to detect on standard scans.

What is linitis plastica?

Linitis plastica, sometimes called 'leather bottle stomach,' is a condition where diffuse cancer cells spread and cause the stomach wall to become thick, rigid, and less flexible. This can lead to symptoms like feeling full very quickly after eating small amounts of food.

Why do doctors take so many random biopsies to check for HDGC?

Because diffuse gastric cancer does not form a solid, visible tumor, it is often invisible on standard scans or endoscopies. Doctors take multiple mapping biopsies to hunt for microscopic signet ring cells that could be hiding anywhere in the stomach lining.

Curated prompts to bring to your next appointment.

1.Does my pathology report show 'signet ring cells' or 'poorly cohesive' cells, and how extensive are these findings?
2.Since this cancer doesn't form a typical lump, how do you know where to take biopsies during an endoscopy?
3.Can you explain how a CTNNA1 mutation changes my risk compared to a CDH1 mutation?
4.Is there any evidence of 'linitis plastica' or thickening of my stomach wall on my recent scans?
5.How does the 'discohesive' nature of these cells affect the type of chemotherapy or treatment that would be used if cancer is found?

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References (20)

1
CDH1 and hereditary diffuse gastric cancer: a narrative review.
Gregory SN, Davis JL
Chinese clinical oncology 2023; (12(3)):25 doi:10.21037/cco-23-36.
PMID: 37303221
2
CTNND1 is involved in germline predisposition to early-onset gastric cancer by affecting cell-to-cell interactions.
Herrera-Pariente C, Bonjoch L, Muñoz J, et al.
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2024; (27(4)):747-759 doi:10.1007/s10120-024-01504-7.
PMID: 38796558
3
Prognosis and outcome in CDH1-mutant lobular breast cancer.
Corso G, Veronesi P, Sacchini V, Galimberti V
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2018; (27(3)):237-238 doi:10.1097/CEJ.0000000000000405.
PMID: 29595757
4
Pancreatic Exocrine Tissue Architecture and Integrity are Maintained by E-cadherin During Postnatal Development.
Serrill JD, Sander M, Shih HP
Scientific reports 2018; (8(1)):13451 doi:10.1038/s41598-018-31603-2.
PMID: 30194315
5
Myosin V facilitates polarised E-cadherin secretion.
Tanasic D, Berns N, Riechmann V
Traffic (Copenhagen, Denmark) 2022; (23(7)):374-390 doi:10.1111/tra.12846.
PMID: 35575181
6
αE-catenin is a candidate tumor suppressor for the development of E-cadherin-expressing lobular-type breast cancer.
de Groot JS, Ratze MA, van Amersfoort M, et al.
The Journal of pathology 2018; (245(4)):456-467 doi:10.1002/path.5099.
PMID: 29774524
7
CDH1 Germline Variants in a Tunisian Cohort with Hereditary Diffuse Gastric Carcinoma.
Ben Aissa-Haj J, Kabbage M, Othmen H, et al.
Genes 2022; (13(3)) doi:10.3390/genes13030400.
PMID: 35327954
8
Case series of three patients with hereditary diffuse gastric cancer in a single family: Three case reports and review of literature.
Hirakawa M, Takada K, Sato M, et al.
World journal of gastroenterology 2020; (26(42)):6689-6697 doi:10.3748/wjg.v26.i42.6689.
PMID: 33268956
9
Early relapses after adjuvant chemotherapy suggests primary chemoresistance in diffuse gastric cancer.
Pattison S, Mitchell C, Lade S, et al.
PloS one 2017; (12(9)):e0183891 doi:10.1371/journal.pone.0183891.
PMID: 28922362
10
The metastatic pattern of intestinal and diffuse type gastric carcinoma - A Dutch national cohort study.
Koemans WJ, Luijten JCHBM, van der Kaaij RT, et al.
Cancer epidemiology 2020; (69()):101846 doi:10.1016/j.canep.2020.101846.
PMID: 33126042
11
E-cadherin loss drives diffuse-type gastric tumorigenesis via EZH2-mediated reprogramming.
Zou G, Huang Y, Zhang S, et al.
The Journal of experimental medicine 2024; (221(4)) doi:10.1084/jem.20230561.
PMID: 38411616
12
Significance of E-cadherin Gene Mutations in Patients With Hereditary Diffuse Gastric Cancer Syndrome: A Systematic Review.
Goud HK, Mehkari Z, Mohammed L, et al.
Cureus 2020; (12(9)):e10406 doi:10.7759/cureus.10406.
PMID: 33062523
13
Molecular evolution of intestinal-type early gastric cancer according to Correa cascade.
Li F, Wang Y, Ping X, et al.
Journal of biomedical research 2024; (39(3)):270-285 doi:10.7555/JBR.38.20240118.
PMID: 39314047
14
Spasmolytic polypeptide-expressing metaplasia (SPEM) cell lineages can be an origin of gastric cancer.
Goldenring JR
The Journal of pathology 2023; (260(2)):109-111 doi:10.1002/path.6089.
PMID: 37145865
15
Anti-fibrotic properties of an adiponectin paralog protein, C1q/TNF-related protein 6 (CTRP6), in diffuse gastric adenocarcinoma.
Iwata Y, Yasufuku I, Saigo C, et al.
Journal of Cancer 2021; (12(4)):1161-1168 doi:10.7150/jca.46765.
PMID: 33442414
16
Signet ring cell carcinoma of the non-ampullary duodenum: A case report.
Mochizuki K, Kondo T, Tahara I, et al.
Pathology, research and practice 2015; (211(10)):801-4.
PMID: 26298633
17
A Case of Primary Signet-Ring Cell Cervical Carcinoma Treated with Chemoradiation, Brachytherapy, and Adjuvant Hysterectomy.
Salmen N, LaBella D, Strumpf K, et al.
Case reports in obstetrics and gynecology 2021; (2021()):5544015 doi:10.1155/2021/5544015.
PMID: 34987874
18
Hereditary diffuse gastric cancer spectrum associated with germline CTNNA1 loss of function revealed by clinical and molecular data from 351 carrier families and over 37 000 non-carrier controls.
Lobo S, Dias A, Pedro AM, et al.
Gut 2026; (75(5)):872-885 doi:10.1136/gutjnl-2024-334601.
PMID: 40998418
19
Endoscopic surveillance with systematic random biopsy for the early diagnosis of hereditary diffuse gastric cancer: a prospective 16-year longitudinal cohort study.
Lee CYC, Olivier A, Honing J, et al.
The Lancet. Oncology 2023; (24(1)):107-116 doi:10.1016/S1470-2045(22)00700-8.
PMID: 36509094
20
Endoscopic Ultrasound Has Limited Utility in Diagnosis of Gastric Cancer in Carriers of CDH1 Mutations.
Kumar S, Katona BW, Long JM, et al.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2020; (18(2)):505-508.e1 doi:10.1016/j.cgh.2019.04.064.
PMID: 31077828

This page explains the biology and genetics of HDGC for educational purposes only. Always consult your genetic counselor or oncologist to understand how specific gene mutations impact your personal health and screening needs.

Get notified when new evidence is published on Hereditary diffuse gastric cancer.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Guide Contents